A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysis

N A Kennedy, E Rhatigan, I D R Arnott, C L Noble, A G Shand, J Satsangi, C W Lees

Research output: Contribution to journalArticlepeer-review

Abstract

Thiopurines maintain remission and modify disease course in inflammatory bowel disease. Use is limited by intolerance and subsequent drug withdrawal in approximately 17% of patients treated with azathioprine. Previous case series have addressed the success rates of re-treatment with mercaptopurine in these individuals.
Original languageEnglish
Pages (from-to)1255-66
Number of pages12
JournalAlimentary Pharmacology and Therapeutics
Volume38
Issue number10
DOIs
Publication statusPublished - Nov 2013

Fingerprint

Dive into the research topics of 'A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysis'. Together they form a unique fingerprint.

Cite this